Ke Chen

ORCID: 0000-0002-4719-491X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Gastric Cancer Management and Outcomes
  • Esophageal Cancer Research and Treatment
  • Inflammatory Biomarkers in Disease Prognosis
  • Bladder and Urothelial Cancer Treatments
  • Cardiac Arrhythmias and Treatments
  • Urinary and Genital Oncology Studies
  • Cancer Diagnosis and Treatment
  • Renal cell carcinoma treatment
  • Cancer-related molecular mechanisms research
  • Appendicitis Diagnosis and Management
  • Lung Cancer Diagnosis and Treatment
  • Metabolism, Diabetes, and Cancer
  • Esophageal and GI Pathology
  • Cardiac electrophysiology and arrhythmias
  • Pneumothorax, Barotrauma, Emphysema
  • Cancer, Lipids, and Metabolism
  • Abdominal Surgery and Complications
  • Atrial Fibrillation Management and Outcomes
  • Cancer, Hypoxia, and Metabolism

Peking University
2022-2025

Peking University Cancer Hospital
2022-2025

First Affiliated Hospital of Soochow University
2023-2024

Soochow University
2023-2024

Tongji Hospital
2024

Huazhong University of Science and Technology
2024

•The CMISG1701 trial assessed the safety and efficacy of nCRT versus nCT followed by MIE for locally advanced bulky ESCC.•The strategy could not improve survival significantly compared with strategy.•The best neoadjuvant therapy ESCC remains a pending issue. BackgroundNeoadjuvant is recommended esophageal cancer, but optimal unclear. We aimed to evaluate chemoradiotherapy (nCRT) chemotherapy (nCT) minimally invasive esophagectomy (MIE) squamous cell carcinoma (ESCC).Patients methodsEligible...

10.1016/j.annonc.2022.10.508 article EN cc-by-nc-nd Annals of Oncology 2022-11-16
Jitendra PS. Sawhney V A Kothiwale Vikas Bisne Rajashekhar Durgaprasad Praveen Jadhav and 95 more Manoj Chopda V. Vanajakshamma Ramdhan Meena G Vijayaraghavan Kamaldeep Chawla Jagan Allu Karen S. Pieper A. John Camm Ajay K. Kakkar Ajay K. Kakkar Jean‐Pierre Bassand A. John Camm David Fitzmaurice Samuel Z. Goldhaber Shinya Goto Sylvia Haas Werner Hacke LG Mantovani Frank Misselwitz Karen S. Pieper Alexander G.G. Turpie Martin van Eickels Freek W.A. Verheugt A. John Camm Jean‐Pierre Bassand Samuel Z. Goldhaber Sylvia Haas Gloria Kayani LG Mantovani Keith A.A. Fox Bernard J. Gersh Héctor Luciardi Harry Gibbs Marianne Brodmann Frank Cools Antônio Carlos Pereira Barretto Stuart J. Connolly Alex C. Spyropoulos John W. Eikelboom Ramón Corbalán Dayi Hu Petr Jánský Jørn Dalsgaard Nielsen Hany Ragy Pekka Raatikainen Jean-Yves Le Heuzey Harald Darius Matyàs Keltai Sanjay Kakkar J.P.S. Sawhney Giancarlo Agnelli Giuseppe Ambrosio Yukihiro Koretsune Carlos Jerjes‐Sánchez Hugo Ten Cate Dan Atar Janina Stępińska Е. П. Панченко Toon Wei Lim Barry Jacobson Seil Oh Xavier Viñolas Mårten Rosenqvist Jan Steffel Pantep Angchaisuksiri Ali̇ Oto Alexander Parkhomenko Wael Al Mahmeed David Fitzmaurice Samuel Z. Goldhaber Dayi Hu Ke Chen Yusheng Zhao H.Q. Zhang Jian‐Zhang Chen Sheng Cao D.W. Wang Yuejin Yang W. Li Yuehui Yin Tao Gao Ping Yang Yu‐Ming Chen Shaohua He Ying Wang Yong Wang Guosheng Fu Xin Li WU Tang-chun Xingxing S. Cheng Xiunan Yan Ren Zhao Margaret Chen L.G. Xiong Peiwen Chen

The Global Anticoagulant Registry in the FIELD–Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which providing important information on baseline characteristics, treatment patterns, and 1-year outcomes patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian recruited this registry. A total of 52,014 AF were enrolled globally; these, 1388 26 sites within India (2012–2016). In India, mean age was 65.8...

10.1016/j.ihj.2018.09.001 article EN cc-by-nc-nd Indian Heart Journal 2018-09-12

The advantages of en bloc resection bladder tumors (ERBT) over transurethral (TURBT) in terms patient prognosis are not yet clear, and there some technical limitations. We aimed to compare the tumor recurrence non-muscle invasive cancer (NMIBC) patients with diameter ≥ 3 cm undergoing either TURBT or thulium laser ERBT.

10.1186/s12885-024-13022-x article EN cc-by-nc-nd BMC Cancer 2024-10-08

To investigate the application value of tumor abnormal protein in patients with type 2 diabetes mellitus complicated lung adenocarcinoma

10.1080/07853890.2023.2293243 article EN cc-by-nc Annals of Medicine 2023-12-12

The increasing number of type 2 diabetes mellitus (T2DM) patients leads to higher rates morbidity and mortality related lung cancer. To investigate the utility proliferating cell nuclear antigen Ki-67 in with adenocarcinoma situ (AIS) complicated by T2DM. One hundred AIS T2DM (group A), 100 alone B), 60 benign lesions C) admitted Department Thoracic Surgery Endocrinology First Affiliated Hospital Soochow University from November 2021 December 2022 were enrolled. expression was compared among...

10.4239/wjd.v16.i2.98423 article EN World Journal of Diabetes 2024-12-30
Coming Soon ...